You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Mifamurtide for the treatment of osteosarcoma

  • Technology appraisal guidance
  • Reference number: TA235
  • Published:  26 October 2011
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Osteosarcoma - mifamurtide: manufacturer submission from Takeda UK

Osteosarcoma - mifamurtide: manufacturer submission from Takeda UK
Osteosarcoma - mifamurtide: manufacturer submission from Takeda UK
07 September 2011
(271.72 Kb 19 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 06 September 2011

Back to top